Stocktoria
Vera Therapeutics, Inc. VERA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-05-14
Vera Therapeutics, Inc. statistics & valuation
Market cap$2.4B
P / B4.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -40.8% | -23.2% | -54.7% | -67.8% | -38.9% |
| Return on equity | -49.6% | -26.4% | -94.4% | -115.8% | -46.9% |
| Debt / equity | 0.12× | 0.09× | 0.49× | 0.32× | 0.07× |
| Current ratio | 13.64 | 25.67 | 7.71 | 4.91 | 10.73 |
Source: SEC EDGAR filings · CIK 0001831828 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.